Blinatumomab: a new era of treatment for adult ALL?

Lancet Oncol. 2015 Jan;16(1):6-7. doi: 10.1016/S1470-2045(14)71183-0. Epub 2014 Dec 16.

Author

Xavier Thomas¹

Affiliation

¹ Hospices Civils de Lyon, Hematology, Lyon-Sud Hospital, 69495 Pierre Bénite, France. Electronic address: xavier.thomas@chu-lyon.fr.

PMID: 25524799
DOI: 10.1016/S1470-2045(14)71183-0

No abstract available

Publication types

Comment

MeSH terms

Antibodies, Bispecific / therapeutic use*
Antineoplastic Agents / therapeutic use*
Female
Humans
Male
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*

Substances

Antibodies, Bispecific
Antineoplastic Agents
blinatumomab